NEW YORK (GenomeWeb News) – Decode Genetics reported after the close of the market Monday that its second-quarter revenues fell 61 percent, but it cut its net loss 28 percent on lower spending.

The Reykjavik, Iceland-based genetic test developer also cautioned in a statement accompanying the results that it has sufficient cash resources to fund its operations only into the second half of its third quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.